ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Common Stock (AVBP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVBP · as of Jun 8, 2026
Key Statistics
Explore ArriVent BioPharma, Inc. Common Stock Data
avbp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The AVBP analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $45.00, representing +47.01% upside from the current price of $30.61.
Competitors & Peers
avbp competitorsAVBP
ARVN
ATXS
DAWN
DNA
ERASStock Performance
Full HistoryAbout ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Common Stock ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patie…
what is arrivent biopharma, inc. common stock · avbp stock overview · arrivent biopharma, inc. common stock company profile · who is arrivent biopharma, inc. common stock ceo · avbp NASDAQ · arrivent biopharma, inc. common stock headquarters · arrivent biopharma, inc. common stock business segments
About Stock Overview & Key Data
ArriVent BioPharma, Inc. Common Stock (AVBP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 26, 2024. As of the latest trading session, AVBP stock price is $30.61, with a market capitalization of $1.4B. The stock has returned +29.15% over the past 12 months and +51.49% year-to-date.
According to 7 Wall Street analysts, the consensus rating for ArriVent BioPharma, Inc. Common Stock stock is Buy, with an average 12-month price target of $45.00. In fiscal year 2025, ArriVent BioPharma, Inc. Common Stock reported revenue of — and net income of -$166.3M. For detailed data — including ArriVent BioPharma, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ArriVent BioPharma, Inc. Common Stock (AVBP) stock price is $30.61. The stock is traded on NASDAQ under the ticker symbol AVBP. The 52-week range is $16.10 – $32.14.